2025-02-04 - Analysis Report
## UnitedHealth Group Inc (UNH) Stock Report

**0. Overview:** UnitedHealth Group Inc (UNH) is a diversified healthcare company offering a range of health benefits programs and related services.

**1. Performance Comparison vs. S&P 500 (VOO):**

UNH's cumulative return is significantly higher than that of the S&P 500 (VOO).

* **UNH Cumulative Return:** 150.21%
* **VOO Cumulative Return:** 119.91%
* **Return Difference:** 30.3%
* **Relative Divergence:** 24.7% (This indicates UNH's outperformance relative to its historical range against VOO).

The provided alpha and beta analysis shows consistent positive alpha (outperformance relative to the market), indicating UNH's ability to generate returns above the benchmark.  Beta values suggest high market sensitivity, but this is consistent with the sector.  Note the negative CAGR in 2022-2025 reflecting market conditions.  MDD (Maximum Drawdown) is generally moderate, except for recent years, possibly reflecting economic uncertainty.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 58.0% | 1.8% | 30.0% | 0.1 | 185.9 |
| 2016-2018  | 66.0% | 10.5% | 47.0% | 0.1 | 212.9 |
| 2017-2019  | 52.0% | 10.5% | 21.0% | 0.3 | 255.5 |
| 2018-2020  | 32.0% | 10.5% | 5.0% | 0.3 | 309.8 |
| 2019-2021  | 96.0% | 9.4% | 26.0% | 0.3 | 449.8 |
| 2020-2022  | 102.0% | 5.5% | 93.0% | 0.3 | 481.0 |
| 2021-2023  | 60.0% | 5.5% | 37.0% | 0.3 | 484.9 |
| 2022-2024  | -24.0% | 16.6% | -57.0% | 0.3 | 473.2 |
| 2023-2025  | -4.0% | 16.6% | -65.0% | 0.2 | 507.4 |


**2. Recent Price Movement:**

* **Closing Price:** $542.49
* **Last Market Price:** $551.40 (1.64% increase from previous close)
* **5-Day Moving Average:** $542.43
* **20-Day Moving Average:** $527.92
* **60-Day Moving Average:** $550.56

The price is slightly above the 5-day and 20-day moving averages but close to the 60-day moving average, suggesting a recent price increase after a period of consolidation.


**3. Technical Indicators:**

* **RSI:** 59.29  (Neither overbought nor oversold, suggesting neutral momentum)
* **PPO:** 0.68 (Positive value indicates bullish momentum)
* **20-Day Relative Divergence Change:** +4.9 (Short-term upward trend)

The recent price increase (Last Market Price data) reflects a short-term upward trend.  The combination of positive PPO and a relatively neutral RSI suggests sustained but not extreme upward momentum.

* **Expected Return:** 239.0% (This is a high expected return and requires careful consideration of the risk involved.  The timeframe is important;  this is a long-term projection.)


**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue        |
|------------|-------|----------------|
| 2024-11-04 | 6.56  | $100.82 B      |
| 2024-08-09 | 4.58  | $98.86 B      |
| 2024-05-09 | -1.53 | $99.80 B      |
| 2023-11-06 | 6.31  | $92.36 B      |
| 2024-11-04 | 6.31  | $92.36 B      | *(Duplicate Entry)*

Revenue remains relatively stable, showing a slight upward trend.  EPS shows significant volatility, with a large negative value in Q2 2024.  Further investigation into the causes of the Q2 2024 EPS is warranted. Note the duplicate entry for 2024-11-04. This likely represents an error in the data provided.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue    | Profit Margin |
|---------|------------|---------------|
| 2024-09-30 | $99.18B   | 21.56%        |
| 2024-06-30 | $97.86B   | 21.52%        |
| 2024-03-31 | $98.78B   | 22.26%        |
| 2023-12-31 | $93.25B   | 22.33%        |
| 2023-09-30 | $91.36B   | 24.51%        |

Revenue is relatively stable, with a slight upward trend. Profit margins are generally high but have fluctuated in the recent quarters.


**Capital and Profitability:**

| Quarter | Equity     | ROE    |
|---------|------------|--------|
| 2024-09-30 | $94.53B   | 6.41%  |
| 2024-06-30 | $89.36B   | 4.72%  |
| 2024-03-31 | $86.69B   | -1.63% |
| 2023-12-31 | $88.76B   | 6.15%  |
| 2023-09-30 | $84.49B   | 6.91%  |

Equity shows a generally upward trend. ROE has shown some volatility, with a negative value in Q1 2024.  This warrants further investigation, potentially aligning it with the negative EPS reported in the same quarter.


**6. Overall Analysis:**

UNH has demonstrated strong historical outperformance compared to the S&P 500, showing consistent positive alpha.  Recent price action suggests a short-term upward trend.  However, the recent earnings report shows some volatility, with significantly lower than expected Q2 2024 EPS and a corresponding impact on ROE.  Further investigation is needed to understand the reasons behind this volatility. While the long-term outlook based on the high projected return is positive,  investors should carefully consider the risks associated with this projection and the observed volatility in recent earnings and ROE.  The unusually high expected return warrants closer scrutiny of the underlying assumptions.  A thorough review of the Q2 2024 results and the overall market conditions is necessary before drawing firm conclusions.
